Lexeo Therapeutics (LXEO) Insider Trading & Ownership $7.01 +0.13 (+1.89%) (As of 03:27 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Lexeo Therapeutics (NASDAQ:LXEO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$636,438.50 Get LXEO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LXEO Insider Buying and Selling by Quarter Ad ProsperityPubCould this be the hottest crypto discovery of all time?I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free…If you want in, Just Click Here Lexeo Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/10/2024Richard Nolan TownsendCEOSell2,500$8.20$20,500.00 11/11/2024Richard Nolan TownsendCEOSell2,500$7.82$19,550.00 10/10/2024Richard Nolan TownsendCEOSell5,000$8.10$40,500.00 9/10/2024Richard Nolan TownsendCEOSell5,000$10.65$53,250.00 8/12/2024Richard Nolan TownsendCEOSell5,000$11.53$57,650.00 7/10/2024Richard Nolan TownsendCEOSell26,969$16.50$444,988.50 (Data available from 1/1/2013 forward) LXEO Insider Trading Activity - Frequently Asked Questions Who is on Lexeo Therapeutics's Insider Roster? The list of insiders at Lexeo Therapeutics includes Fund Vi L.P. Omega, and Richard Nolan Townsend. Learn more on insiders at LXEO. What percentage of Lexeo Therapeutics stock is owned by insiders? 4.50% of Lexeo Therapeutics stock is owned by insiders. Learn more on LXEO's insider holdings. Which Lexeo Therapeutics insiders have been buying company stock? The following insider purchased LXEO shares in the last 24 months: Fund Vi L.P. Omega ($4,999,995.00). How much insider buying is happening at Lexeo Therapeutics? Insiders have purchased a total of 454,545 LXEO shares in the last 24 months for a total of $4,999,995.00 bought. Which Lexeo Therapeutics insiders have been selling company stock? The following insider sold LXEO shares in the last 24 months: Richard Nolan Townsend ($636,438.50). How much insider selling is happening at Lexeo Therapeutics? Insiders have sold a total of 46,969 Lexeo Therapeutics shares in the last 24 months for a total of $636,438.50 sold. Lexeo Therapeutics Key ExecutivesMr. R. Nolan Townsend (Age 43)CEO & Director Compensation: $864.34kDr. Eric Adler M.D. (Age 50)Chief Medical Officer & Head of Research Compensation: $623.4kMs. Jenny R. Robertson (Age 49)Chief Business & Legal Officer Compensation: $617.9kDr. Ronald G. Crystal M.D.Co-Founder, Chief Scientific Advisor & Member of Scientific Advisory BoardDr. Paul B. McCormac Ph.D. (Age 54)Chief Technical Officer Compensation: $471.73kDr. Jordan Shin M.D.Ph.D., Senior Vice President of Clinical Development & Translational Science, CardiologyDr. Jordan S. Dubow M.D. (Age 45)Head of CNS Clinical Development Dr. Sandi See Tai M.D. (Age 53)Chief Development Officer Mr. Ryan McHenryVP & Corporate Controller More Insider Trading Tools from MarketBeat Related Companies Collegium Pharmaceutical Insider Buying Gyre Therapeutics Insider Buying ArriVent BioPharma Insider Buying Nuvation Bio Insider Buying Avadel Pharmaceuticals Insider Buying Phibro Animal Health Insider Buying Immunome Insider Buying Poseida Therapeutics Insider Buying Zymeworks Insider Buying Pliant Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-ReportServiceNow: Will the High-Flyer Finally Split in 2024? This page (NASDAQ:LXEO) was last updated on 12/16/2024 by MarketBeat.com Staff From Our PartnersMedia Is Mocking Elon, But Wait Until They See This DemoElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexeo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
